Kodu・Aktsiate loetelu・Accuray Inc

Accuray Inc

Suletud

SektorTervishoid

0.27 -12.9

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.28

Max

0.31

Põhinäitajad
By Trading Economics
Sissetulek	2M -12M
Müük	2.6M 105M
Aktsiakasum	-0.07
Kasumimarginaal	-11.259
Töötajad	990
EBITDA	2.5M -813K

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+12.9% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	12. aug 2026

Turustatistika
By TradingEconomics
Turukapital	-22M 32M
Eelmine avamishind	13.17
Eelmine sulgemishind	0.27

Uudiste sentiment

By Acuity

50%

175 / 340 Pingereas Healthcare

Accuray Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2026, 20:02 UTC

Accuray Inc shares are higher today amid positive market sentiment and declining crude oil prices. Comments on potential peace talks with Iran also support the move.

3. aug 2026, 19:31 UTC

Accuray Inc shares are lower today, with no specific news identified to explain the decline, despite broader market gains.

31. juuli 2026, 23:16 UTC

Accuray Inc shares are lower in after-market trading, with no specific news identified. Broader market pressures also impacted other tech companies, including Apple Inc.

30. juuli 2026, 23:51 UTC

Accuray Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market conditions remain mixed amid geopolitical concerns.

29. juuli 2026, 23:02 UTC

News

Accuray Inc. announced a $40 million debt exchange and $15 million equity investment to enhance its financial position, with shares trading higher after market close.

28. juuli 2026, 23:16 UTC

Accuray Inc shares are trading lower in after-market hours, reflecting broader market pressures in the technology sector amid concerns over AI spending and competition.

27. juuli 2026, 19:32 UTC

Accuray Inc's shares are declining today, hitting a low after an early high. Broader market conditions, including falling oil prices, may be influencing sentiment.

24. juuli 2026, 19:11 UTC

Accuray Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains near its one-month low.

22. juuli 2026, 18:51 UTC

Accuray Inc. shares are trading flat, remaining 7.82% below their 20-day moving average amid a lack of upward momentum.

20. juuli 2026, 19:31 UTC

Accuray Inc shares are lower today, diverging from a recent trend of higher closes. Broader market dynamics may be impacting investor sentiment.

Võrdlus sarnastega

Hinnamuutus

Accuray Inc Prognoos

Hinnasiht

By TipRanks

12.9% tõus

12 kuu keskmine prognoos

Keskmine 0.35 USD 12.9%

Kõrge 0.35 USD

Madal 0.35 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Accuray Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Accuray Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

175 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.